Biomarin Pharmaceutical (BMRN) EV to FCF (2020 - 2026)
Biomarin Pharmaceutical's EV to FCF was 13.82 in Q2 2026, up 5.3% from 13.13 a year earlier and up 21.9% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) EV to FCF (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biomarin Pharmaceutical's EV to FCF was 6.69 through Jun 30, 2026, down 19.6% year-over-year; for FY2025, it was 13.61, down 41.8% from FY2024.
- EV to FCF has now declined for three consecutive years.
- In earlier years, EV to FCF was 23.39 in FY2024 (-91.4%), 273.48 in FY2023 (-16.4%), 327.31 in FY2022 (+348.9%) and 72.91 in FY2021.
- The Q2 2026 figure marks the highest quarterly EV to FCF since Q1 2025.
- Compared with a year earlier, EV to FCF was higher in 1 of the last eight quarters, with an average decline of 61.3%.
- The best year-over-year quarter for EV to FCF over five years was Q4 2022 (growth of 348.9%); the worst was Q4 2024 (a decline of 91.4%).
- Per Business Quant data, BMRN's EV to FCF in the three quarters before Q2 2026 was 11.34 (Q1 2026), 13.61 (Q4 2025) and 10.73 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.82 |
| Mar 31, 2026 | 11.34 |
| Dec 31, 2025 | 13.61 |
| Sep 30, 2025 | 10.73 |
| Jun 30, 2025 | 13.13 |
| Mar 31, 2025 | 19.68 |
| Dec 31, 2024 | 23.39 |
| Sep 30, 2024 | 38.96 |
| Jun 30, 2024 | 62.60 |
| Mar 31, 2024 | 85.40 |
| Dec 31, 2023 | 273.48 |
| Sep 30, 2023 | 442.69 |
| Jun 30, 2023 | 301.49 |
| Mar 31, 2023 | 554.82 |
| Dec 31, 2022 | 327.31 |
| Sep 30, 2022 | 218.42 |
| Jun 30, 2022 | 914.49 |
| Mar 31, 2022 | 282.62 |
| Dec 31, 2021 | 72.91 |
| Sep 30, 2021 | 71.98 |
API Access
Biomarin Pharmaceutical EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();